Friday, July 31, 2026

MEOVV Reveals Secrets Behind Their Captivating Debut Track

The Black Label's MEOVV made a bold debut with their single "MEOW," showcasing their unique style and skills, driven by Teddy's guidance.

Long-Term Study Finds North Korean Defector Youth Face 30% Higher Risk of Mental Disorders

North Korean defector children face 1.3 times higher risk of mental disorders like PTSD and ADHD than South Korean peers, study finds.

Marco Rubio Unveils FORGE With 55 Partners: A New Critical Minerals Alliance Built Around Price Floors

The U.S. launched FORGE to diversify critical mineral supply chains, reducing reliance on China and enhancing global cooperation.

Tag: obesity

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How Hanmi Pharmaceutical’s AI Platform is Revolutionizing Obesity Drug Development in 2026

Hanmi Pharmaceutical leverages AI for drug discovery, developing innovative obesity treatments and advancing to clinical trials.

Novo Nordisk vs Eli Lilly: Is Weight Loss Advertising Misleading?

Novo Nordisk sues Eli Lilly for misleading ads on obesity drugs, claiming false comparisons and seeking corrective action in court.

How Salidroside from Korean Ginseng Can Combat Insulin Resistance and Prevent Diabetes

Research reveals salicin from tianma improves insulin resistance, aiding diabetes prevention and intestinal health restoration.

Smoking Raises Fatty Liver Risk by Up to 1.5 Times Among Young Adults

Young adult smokers face a higher risk of fatty liver disease, with significant findings on its impact regardless of obesity or alcohol consumption.

Can GLP-1 Medications Reduce Breast Cancer Risk? New Research Reveals Surprising Findings

GLP-1 drugs show promise in cancer prevention and progression inhibition, expanding beyond obesity treatment to chronic disease management.

AstraZeneca’s Elecoglipron: Can This New Weight Loss Pill Compete with GLP-1 Giants?

AstraZeneca's new weight-loss pill, elecoglipron, shows promising results in trials, competing with existing obesity treatments.

Inventage Lab Secures Patent for Semaglutide Formulation Aimed at Improving Oral Bioavailability

Inventage Lab secures a patent for a liposome formulation enhancing semaglutide's bioavailability, aiming to lead in obesity treatment.

Novo Nordisk’s Oral Wegovy Just Put Up a Number That Could Change the Obesity Drug Race

Novo Nordisk's oral obesity treatment, Wegovy, saw $400M in Q1 2026 sales, exceeding estimates and indicating strong market demand.

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

Unlocking Weight Loss: How GB102 Probiotics Enhance GLP-1 Obesity Drugs

GI Longevity's GB102 probiotic enhances weight loss with GLP-1 medications, reducing rebound gain and improving blood sugar control.

JW Pharmaceuticals Secures Exclusive Rights for Innovative GLP-1 Drug Vopaglutide in South Korea

JW Pharmaceutical secures exclusive rights for Vopaglutide, a promising treatment for diabetes and obesity, with significant milestone payments.

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

GLP-1 Weight Loss Injections: Are They Causing Gallstone Surge in Asia?

GLP-1 obesity treatments are linked to increased gallstone risk, especially during rapid weight loss, with cases doubling in South Korea.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.